EPO

AMERICAN COLLEGE OF SPORTS MEDICINE. Position stand on the use of blood doping as an ergogenic aid. Med Sci Exerc 1996 28:I-VIII.

 

ADAMSON JW, VAPNEK D. Recombinant erythropoietin to improve athletic performance. N Engl J Med 1991 324:698-699.

 

BAKRIS GL, SAUTER ER, HUSSLEY JL, FISHER JW, GABER AO, WINSETT R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythocytosis after renal transplantation. N Engl J Med 1990 323:86-90.

 

BALSOM PD, EKBLOM B, SJÖDIN B. Enhanced oxygen availability during high intensity intermittent exercise decreases anaerobic metabolite concentrations in blood. Acta Physiol Scand 1994 150:455-456.

 

BÁRÁNY P. Erytropoietin högeffektivt vid renal anemi men förskrivning bör ske med forsigtighet. Läkartidningen 1991 88:2855-2857.

 

BERGLUND B. Development of techniques for the detection of blood doping in sport. Sports Med 1988 5:127-135.

 

BERGLUND B, EKBLOM B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991 229:125-130.

 

BRUNKHORST RB, NONNAST-DANIEL KM, KOCH, FREI U. Hypertension as a possible complication of recombinant human erythropoietin therapy. Contrib Nephrol 1991 88:118-125.

 

CASONI I, RICCI G, BALLARIN E, BORSETTO C, GRAZZI G, GUGLIELMINI C, MANFREDINI F, MAZZONI G, PATRACCHINI M, DE PAOLI VITALI E, RIGOLIN F, BARTALOTTA S, FRANZÉ GP, MASOTTI M, CONCONI F. Hematological indices of erythropoietin administration in athletes. Int J Sports Med 1993 14:307-311.

 

CATLIN DH, HATTON CK. Use and abuse of anabolic and other drugs for athletic enhancement. Adv Intern Med 1991 36:399-424.

 

CELSING F, SVEDENHAG J, PIHLSTEDT P, EKBLOM B. Effects of anaemia and stepwise-induced polycythamia on maximal aerobic power in individuals with high and low haemoglobin concentrations. Acta Physiol Scand 1987 129:47-54.

 

COWART VS. Erythropoietin: a dangerous new form of blood doping? Physician Sportsmed 1989 17:115-118.

 

EICNER ER. Sports anemia, iron supplements, and blood doping. Med Sci Sports Exerc 1992 24:S315-S318.

 

EICHNER ER. Better dead than second. J Lab Clin Med 1992 9:359-360.

 

EKBLOM B, BERGLUND B. Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1991 1:88-93.

 

FLAHARTY KK, CAROJ, ERSLEV A, WHALEN JJ, MORRIS EM, BJORNSSON TD, VLASSES PH. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther 1990 47:557-564.

 

GAREAU R, BRISSON GR, AYOTTE C, DUBÉ J, CARON C. Erythropoietin doping in athletes: possible detection through measurement of fibrinolytic products. Thrombosis and Heamostasis 1992 68:481-482.

 

GAREAU R, GAGNON MG, THELLEND C, CHÉNARD C, AUDRAN M, CHANAL J-L, AYOTTE C, BRISSON GR. Transferrin Soluble Receptor: a possible probe for detection of erythropoietin abuse by athletes. Horm Metab Res 1994 26:311-312.

 

GHAPHERY NA. Performance-enhancing drugs. Sports Med 1995 26:433-442.

 

GOODNOUGH LT, RUDNICK S, PRICE TH, BALLAS SK, COLLINS ML, CROWLEY JP, KOSMIN M, KRUSKALL MS, LENES BA, MENITOVE JE, SILBERSTEIN LE, SMITH KJ, WALLAS CH, ABELS R, VON TRESS M. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989 321:1163-1168.

 

JELKMANN W. Biology of erythropoietin. Clin Investig 1994 72:S3-S10.

 

JONES M, TUNSTALL DS. Blood doping – a literature review. Br J Sp Med 1989 23:84-88.

 

JUVONEN E, IKKALA E, FYHRQUIST F, RUUTU T. Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 1991 78:3066-3069.

 

KICMAN AT, COWAN DA. Peptide hormones and sport: misuse and detection. Br Med Bull 1992 48:496-517.

 

KRÄMER BK, RISLER T. Sport and niere. Internist (Berl) 1992 33:150-153.

 

LONGMORE GD. Erythropoietin receptor mutations and olympic glory. Nat Genetics 1993 4:108-110.

 

McMAHON FG, VARGAS R, RYAN M, JAIN K, ABELS RI, PERRY B, SMITH IL. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 1990 76:1718-1722.

 

MURRAY TH. Erythropoietin: Another violation of ethics. Physician Sportsmed 1989 17:39-42.

 

REMACHA AF, ORDONEZ J, BARCELO MJ, GARCIA-DIE F, ARZA B, ESTRUCH A. Evaluation of erythropoietin in endurance runners. Haematologia 1994 79:350-352.

 

SALMONSON T, DANIELSON BG, WIKSTRÖM B, The pharmakokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br J Clin Pharmacol 1990 29:709-713.

 

SCOTT WC. The abuse of erythropoietin to enhance athletic performance. JAMA 1990 264:1660.

 

SIMON TL. Induced erythrocythemia and athletic performance. Sem Hematol 1994 31:128-133.

 

SIMPSON RE, PHILLIS JW. Adenosine in exercise adaptation. Br J Sports Med 1992 26:54-58.

 

SINGBARTL G. Adverse events of erythropoietin in long-term and in acute/short-term treatment. Clin Investig 1994 72:S36-S43.

 

SKIKNE BS, COOK JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992 120:746-751.

 

SMITH DA, PERRY PJ. The efficacy of ergogenic agents in athletic competition. Part II: Other performance-enhancing agents. Ann Pharmacother 1992 26:653-659.

 

SNELL PG. RHuEPO: sport’s newest drug threat. Orthop Rev 1992 21:113-116.

 

SUNDAL E, KAESER U. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year’s treatment in a European multicenter study of 150 haemodialysis patients. Nephrol Dial Transplant 1989 4:979-987.

 

USAMI S. Physiological significance of blood rheology. Biorheology 1982 19:29-46.

 

WADLER GI. Drug use update. Sports Med 1994 78:439-455.

 

WALLS J. Haemoglobin – is more better? Nephrol Dial Transplant 1995 10(suppl 2):56-61.

 

WIDE L, BENGTSSON C, BERGLUND B, EKBLOM B. Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 1995 27:1569-1576.

 

WILLIAMS C. Haemoglobin – is more better? Nephrol Dial Transplant 1995 10 (Suppl 2):48-55.

 

ASHENDEN MJ et al. ”Live high, train low” does not change the total haemoglobin mass of male endurance sthletes sleeping at a simulated altitude of 3000 m for 23 nights. Eur J Appl Physiol. Oct 1999; 80(5): 479-84.A.

 

ASHENDEN MJ et al. Effects of a 12-day ”live high, train low” camp on reticulocyte production and haemoglobin mass in elite female road cyclists. Eur J Appl Physiol 1999; 80 472-78. B.

 

ASHENDEN MJ et al. Simulated moderate altitude elevates serum erythropoietin but does not increase reticulocyte production in well-trained runners. Eur J Appl Physiol 2000; 81:428-35

 

AUDRAN M et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc. 1999; 31(5): 639-45.

 

BIRKELAND KI et al. Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc. Jul. 2000; 32(7): 1238-43.

 

GE R-L et al. Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J Appl Physiol 2002; 92:2361-67.

 

GORE CJ et al. Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica 2003; 88:333-44.

 

JELKMANN W. Erythropoietin: structure, control of production and function. Physiol Rev 1992; 72(2): 449-89.

 

KOISTINEN PO et al. EPO, red cells and serum transferrin receptor in continuos and intermittent hypoxia. Med Sci Sports Exerc. Apr. 2000; 32(4):800-4.

 

LASNE F et al. Recombinant erythropoietin in urine. Nature. Jun. 2000; 405(6787):635.

 

PARISOTTO R et al. A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica. 2000; 85:564-72.A.

 

PARISOTTO R et al. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes. Int J Sports Med 2000; 21:471-79.B.

 

STRAY-GUNDERSEN J et al. ”Living high, training low” altitude training improves sea level performance in male and female elite runners. J Appl Physiol 2001; 91:1113-20.